Amanda McDowell

How we delivered 80 randomizations for an accelerated CV recruitment project [patient recruitment case study]

Across all genders and ethnic groups, cardiovascular disease is the leading cause of death in the United States. It is estimated that 8.8 million adults above age 20 have had a heart attack, and 7.6 million have had a stroke. These events can occur for many reasons, but a lesser-known risk factor is elevated lipoprotein(a) (Lp(a)). 

Continue reading

The importance of a Match journey for patients and a roadmap for the future with Sam Veeck

At Antidote, we understand that it can be difficult for patients to discover how to participate in clinical trials — which is why creating a patient-centric user experience for our clinical trial search tools is one of our main priorities. 

Continue reading

Creating communities around medical research: Q&A with Heart Valve Voice

Medical research is how new treatments and therapies move forward, but challenges surrounding patient recruitment can often lead to delays. Patients often have misconceptions about participating in a clinical trial — and if they are interested, they often aren’t sure where to begin.

Continue reading

Where to find support if you experience mitral valve regurgitation

Mitral valve regurgitation is a common kind of heart disease in the United States. Not only does it impact many people today, but its prevalence is expected to double by 2030. 

Continue reading

What is C3G and what resources are available for those affected?

Complement 3 glomerulopathy (C3G) is a rare type of kidney disease, estimated to impact just 1 to 2 million people worldwide. C3G is a genetically inherited disorder that impacts all races and genders equally, and the average patient is diagnosed between the ages of 21 and 26. 

Continue reading

5 ways to lower clinical trial patient recruitment costs

The process of getting a new drug to market is an expensive one. Between 2009 and 2018, U.S. biopharmaceutical companies spent about $1 billion per drug according to an analysis published in JAMA, and other studies have found that it can cost up to $2.8 billion to bring a new therapy to market. In 2019 alone, research and development spending totaled $186 billion for the global pharmaceutical ...

Continue reading

The importance of diversity in kidney disease trials: A Q&A with the American Kidney Fund

Kidney diseases are one of the top causes of death in the United States, and worldwide, they impact nearly 10% of the population each year. Because chronic kidney disease typically has no cure, it is vital that medical research takes place to find new and more effective treatments for those who have been diagnosed.

Continue reading

Atopic dermatitis research round-up

Atopic dermatitis is a type of eczema, a skin condition caused by an overactive immune system that can lead to redness, blotchiness, and itching, typically on the face, arms, and legs. Atopic dermatitis is the most common type of eczema, impacting more than 9.6 million children and 16.5 million adults worldwide.

Continue reading

Melanoma clinical trials: A Q&A with the Melanoma Research Alliance

Skin cancer is more common than any other type of cancer, and melanoma causes a large majority of skin cancer-related deaths. While awareness surrounding melanoma and the importance of sun protection has risen in recent years, CDC research shows that melanoma rates have still doubled over the last three decades.

Continue reading

10 conditions that cause memory loss

Not being able to recall an actor’s name or where you set down your keys is not always a major concern, but if these incidents are happening often — or causing you to forget life’s more important details — it’s understandable to worry.

Continue reading

Get our latest posts in your inbox